Latest Content

Mary Beth Yackey, OD, outlines all that you need to know about the role of oculomics in eye care.

Catch up on the top stories in optometry during the week of September 14-September 18.

A comparison of ETDRS charts using Latin letters, Tumbling E, and Landolt C optotypes found the alternatives are comparable to letter acuity at the population level.

Vision testing results from 384 public transport drivers in Mumbai found the Visiolite 4K screener accurately matched standard assessments while cutting screening time by 65%.

In the latest episode of The Independent Advantage, Maria Sampalis, OD, gives a resounding "absolutely not" when posited with the question of whether or not eye care providers will be replaced by AI.

A recent study found that migraines were associated with higher adverse vision outcomes in a cohort of Norwegian adolescents.

Jem Martin, OD, discusses the accommodations and referrals any provider can offer, the red flags that should raise suspicion of CVI, and how the free TEACHCVI screening tool works in practice.

AMA resolution backs classifying myopia as a disease, aiming to expand insurance coverage for pediatric myopia control treatments.

Optometrists should know what is expected, what is concerning, and when to contact the surgeon.

Startup S5G Therapeutics aims to move ubiquinol technology from the laboratory toward treatments for dry eye, Fuchs dystrophy, and other corneal conditions.

Mogenry (sonpiretigene isteparvovec, MC-010) is a gene therapy for retinitis pigmentosa with severe vision loss.

Heru's PretestPro runs 4 pretesting exams in about 90 seconds on the Heru Prime wearable platform and reaches all current and future customers via free software update.

In the first episode of the second season of The Independent Advantage, Diana Canto-Sims, OD, chats with practice owner Maria Sampalis, OD, on why artificial intelligence has boomed in practice ownership spaces.